Technology
Updated first day of trading in subscription rights and paid-up subscribed shares
Published
1 day agoon
By
STOCKHOLM, Sept. 15, 2026 /PRNewswire/ — SciBase Holding AB (publ) (“SciBase” or the “Company”) today announces that the Company has resolved to update the first day of trading in subscription rights and paid subscribed shares (“BTA”) on Nasdaq First North Growth Market in the Company’s ongoing rights issue of shares (the “Rights Issue”). According to the preliminary timetable, the first day of trading in subscription rights and BTAs was to be 15 September 2026. Under the updated timetable, the first day of trading in subscription rights and BTAs will be 16 September 2026.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD REQUIRE ADDITIONAL PROSPECTUSES, REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED UNDER SWEDISH LAW, IS PROHIBITED OR WOULD OTHERWISE BE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION, OR CANNOT BE MADE WITHOUT THE APPLICATION OF AN EXEMPTION FROM SUCH MEASURES. SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE FOR FURTHER INFORMATION.
The subscription period in the Rights Issue remains unchanged and runs from 15 September 2026 up to and including 29 September 2026.
Updated timetable for the Rights Issue
Subscription period
15-29 September 2026
Trading in subscription rights
16-24 September 2026
Trading in paid subscribed shares (BTA)
16 September – 16 October 2026
Expected announcement of the outcome of the Rights Issue
1 October 2026
For further information, please contact:
Michael Colérus, Chief Financial Officer, telephone +46 70 341 34 72
This information was submitted for publication, through the agency of the contact persons set out above, on 15 September 2026 at 11.15 CEST.
Certified Adviser (CA):
DNB Carnegie Investment Bank AB (publ)
Telephone: +46 8 588 68 570,
E-mail: certifiedadviser@carnegie.se
About SciBase:
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015 and the company’s Certified Adviser is DNB Carnegie Investment Bank AB (publ). Learn more at www.scibase.com. For press releases and financial reports visit: http://investors.scibase.se/en/pressreleases
Important information:
The publication, release or distribution of this press release may in certain jurisdictions be subject to restrictions by law, and persons in the jurisdictions in which this press release has been made public or distributed should inform themselves about, and comply with, such legal restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with the applicable rules in each jurisdiction.
The availability of the Rights Issue to holders not resident in Sweden may be affected by the legislation of the relevant jurisdiction in which they are located. Holders not resident in Sweden should inform themselves about, and comply with, all applicable laws and regulations.
This press release does not constitute an offer of, or an invitation to, acquire or subscribe for any securities in SciBase in any jurisdiction, either from SciBase or from anyone else. This press release is not a prospectus within the meaning of Regulation (EU) 2017/1129 (the “Prospectus Regulation”) and has not been approved by any regulatory authority in any jurisdiction. No prospectus will be prepared in connection with the Rights Issue. The Company has prepared and published an information document in respect of the Rights Issue. The information document is available on the Company’s website (https://investors.scibase.se).
This press release does not identify, and does not purport to identify, any risks (direct or indirect) that may be associated with an investment in the Company. The information in this press release is intended only to describe the background to the Rights Issue and does not purport to be complete or exhaustive. No representation is made as to the accuracy or completeness of the information in this press release.
This press release does not constitute an offer of, or an invitation to, acquire or subscribe for securities in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended from time to time (the “Securities Act”), and may not be offered or sold in the United States absent registration, or an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, in or into the United States, Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa, South Korea or any other jurisdiction in which such release, publication or distribution of this information would be unlawful or where such action is subject to legal restrictions or would require registration, or measures other than those required under Swedish law. Actions contrary to this instruction may constitute a violation of applicable securities legislation.
Forward-looking statements
Matters discussed in this press release may contain forward-looking statements. Forward-looking statements are all statements that do not relate to historical facts and events, as well as statements relating to the future which, for example, contain expressions such as “anticipates”, “intends”, “may”, “will”, “should”, “estimates”, “believes”, “could”, “plans”, “continues”, “potential”, “estimates”, “forecasts”, “known” or similar expressions. In particular, these statements relate to future results, financial position, cash flows, plans and expectations regarding the company’s operations and management, future growth and profitability, as well as the general economic and regulatory environment and other circumstances affecting the company, many of which are in turn based on further assumptions, such as the absence of changes in existing political, legal, tax, market or economic conditions or in applicable laws (including, but not limited to, accounting principles, accounting methods and tax policies), which, individually or together, may be material to the company’s results or its ability to conduct its operations. Although the Company considers that these assumptions were reasonable when they were made, they are by their nature subject to significant known and unknown risks, uncertainties, contingencies and other important factors that are difficult or impossible to predict and that may be beyond the Company’s control. Such risks, uncertainties, contingencies and other material factors may cause actual events to differ materially from the expectations expressed or implied in such forward-looking statements. Prospective investors should therefore not place undue reliance on the forward-looking information contained herein, and prospective investors are strongly recommended to read those sections of the information document that contain a more detailed description of factors that may affect the Company’s business and the market in which the Company operates. The information, opinions and forward-looking statements in this press release are valid only as at the date of this press release and may be subject to change without notice.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Main/12371/4396176/4270011.pdf
PR – new first day of trading TR and BTA
View original content:https://www.prnewswire.co.uk/news-releases/updated-first-day-of-trading-in-subscription-rights-and-paid-up-subscribed-shares-302878842.html
You may like
Technology
Diagnostic Imaging Market to Reach US$ 33.2 Bn by 2031, Growing at 4.6% CAGR: New Report by Wissen Research
Published
3 minutes agoon
September 16, 2026By
Rising Demand for Early Disease Detection and AI-Enabled Imaging Drives Steady Market Expansion Through 2031
SHERIDAN, Wyo., Sept. 16, 2026 /PRNewswire/ — The global diagnostic imaging market is projected to grow from USD 26.5 billion in 2026 to USD 33.2 billion by 2031, registering a CAGR of 4.6% during the forecast period (2026–2031), according to a new study by Wissen Research.
Growth is being driven by rising chronic disease prevalence, an expanding geriatric population, and increasing demand for earlier and more precise disease detection. AI-assisted imaging, 3D/4D visualization, and portable imaging devices are improving diagnostic accuracy, streamlining radiology workflows, and extending imaging access across hospitals, outpatient clinics, emergency settings, and rural healthcare facilities.
See the Full Data Behind This Forecast — Get a Free Sample Report:
Where the Technology Is Heading: AI Moves Into the Scanner Itself
The most significant shift in diagnostic imaging is not happening after the scan — it is happening during it. Major manufacturers are embedding deep learning reconstruction (DLR) algorithms directly into image acquisition pipelines, clearing signal-level noise as data is captured rather than cleaning up images afterward.
The clinical impact is measurable. GE HealthCare’s Sonic DL sequence now enables complex multi-sequence brain and joint MRI protocols to complete in under 15 minutes, allowing hospitals to increase daily throughput per scanner substantially without new capital equipment. Radiology remains the leading specialty for AI-enabled device clearances, with more than 1,100 cleared by the U.S. FDA to date.
Alongside this, cloud-native PACS and teleradiology platforms are replacing on-premise image archives, enabling remote reads across multi-site networks and reducing reporting turnaround times. Photon-counting CT and hybrid imaging systems are pushing resolution higher while lowering radiation dose, supporting earlier detection in oncology, cardiology, and neurology.
What’s Fueling Growth in the Diagnostic Imaging Market
AI-Enabled Imaging Adoption: AI-based systems are improving diagnostic precision, shortening scan-to-diagnosis time, and raising patient throughput across care settings.Cloud PACS and Teleradiology Expansion: Remote reading platforms are accelerating reporting and improving specialist access across distributed hospital networks.Photon-Counting CT Commercialization: Ultra-high-definition imaging with reduced radiation exposure is shortening replacement cycles for high-end equipment.Portable and Handheld Imaging: Point-of-care ultrasound and mobile systems are expanding diagnostic access in emergency departments, outpatient centers, and rural facilities.Safer Contrast Agents: Non-nephrotoxic imaging options are extending diagnostic access to chronic kidney disease patients.Certified Refurbished Systems: Lower capital barriers are enabling imaging infrastructure expansion across developing markets.
Need Data Specific to Your Region or Segment? Request a Custom Report
Challenges Facing the Diagnostic Imaging Market
Reimbursement compression is emerging as the sector’s most pressing operational constraint. The Centers for Medicare & Medicaid Services introduced an efficiency adjustment in the 2026 Medicare Physician Fee Schedule that permanently reduces work relative value units by 2.5% across roughly 7,700 diagnostic and procedural codes. New combined head and neck CTA codes have produced global payment reductions of up to 30.8%. The result is a growing misalignment between what providers invest in premium scanners and what public payers reimburse — pushing many networks to extend equipment life cycles rather than upgrade.
Beyond reimbursement, high acquisition and maintenance costs for MRI and CT systems remain a barrier for community hospitals and providers in developing markets. A persistent shortage of qualified radiologists is contributing to reporting backlogs, while the shift to cloud-based imaging raises data security and cybersecurity considerations for healthcare providers.
Recent Strategic Developments in the Diagnostic Imaging Market
In May 2026, GE HealthCare introduced next-generation SIGNA MRI technologies and AI-based workflow solutions at ISMRM 2026, including new 3T and helium-free MRI systems, deep learning imaging technologies, and cloud-based research tools.
Also in May 2026, Siemens Healthineers launched an integrated workflow solution for CT-guided percutaneous coronary interventions, combining CT imaging, plaque analysis, procedural planning, and cath lab guidance in a single application.
In March 2026, Samsung Medison consolidated its U.S. medical imaging divisions, NeuroLogica and Boston Imaging, under the Samsung HME America brand, expanding into AI ultrasound, digital radiography, portable CT, and photon-counting detector technologies.
In February 2026, Fujifilm Holdings launched the ARIETTA Deep Insight x ultrasound platform, applying AI and deep learning to improve image quality, with automated workflow tools and real-time virtual sonography.
Key Insights from Diagnostic Imaging Market Analysis
X-ray systems led the market by modality in 2025, supported by the highest global procedure volumes of any modality, lower installation and shielding requirements, and continued analog-to-digital replacement demand.2D imaging held the largest share by technology type in 2025, driven by faster acquisition and turnaround times, lower infrastructure needs, and the fact that most AI triage algorithms were built around standard 2D radiography and ultrasound workflows.North America held the largest regional share in 2025, supported by strong reimbursement, high per-capita imaging volumes, and large health systems with significant purchasing capacity.Asia-Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, rising healthcare expenditure, and growing adoption of AI-enabled and portable imaging across urban and underserved areas.
Key Players in the Diagnostic Imaging Market
Leading companies are focused on embedding AI into imaging platforms, expanding cloud and enterprise imaging capabilities, and broadening portable and point-of-care portfolios.
Company
Key Focus Area
GE HealthCare (US)
SIGNA MRI platforms and deep learning reconstruction
Siemens Healthineers (Germany)
CT, interventional imaging, and integrated procedural workflows
Philips (Netherlands)
Enterprise imaging, cloud PACS, and AI-enabled platforms
Canon Medical Systems (Japan)
CT, MRI, and ultrasound imaging systems
Fujifilm Holdings (Japan)
AI-driven ultrasound and enterprise imaging management
Samsung Medison (South Korea)
AI ultrasound, portable CT, and photon-counting detectors
Hitachi Healthcare (Japan)
Diagnostic imaging systems portfolio
Shimadzu Corporation (Japan)
X-ray and fluoroscopy imaging systems
Hologic (US)
Mammography and breast imaging
United Imaging Healthcare (China)
Advanced imaging systems manufacturing
Butterfly Network (US)
Handheld point-of-care ultrasound
Nano-X Imaging (Israel)
Digital X-ray and imaging access technologies
Regional Analysis and Growth Opportunities
North America leads the diagnostic imaging market, underpinned by advanced healthcare infrastructure, high imaging procedure volumes, favorable reimbursement for advanced modalities, and sustained hospital investment in premium imaging technology. An aging population and the formation of large health networks and group purchasing organizations continue to support long-term equipment and service contracts.
Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure expansion, rising healthcare expenditure, and improving access to advanced diagnostics across China, India, Japan, South Korea, and Australia. Government investment in healthcare modernization and the growth of private hospitals and imaging centers are accelerating adoption, while AI-enabled and portable systems are extending diagnostic capability into underserved areas.
Europe, Latin America, and the Middle East & Africa complete the report’s regional coverage, with growth shaped by screening program expansion and imaging infrastructure investment.
Wissen Research’s healthcare technology analysts are available to walk through findings specific to your market, region, or competitive set.
Need Insights Specific to Your Business? Request a Customized Version of This Report:
Market Segmentation Snapshot
The global diagnostic imaging market is segmented across modality, technology, portability, architecture, application, end user, and region:
By Modality Type: X-RayUltrasoundComputed Tomography (CT)Magnetic Resonance Imaging (MRI)Nuclear Imaging (PET/SPECT)MammographyFluoroscopyBy Technology Type: 2D Imaging3D/4D ImagingAI-Enabled ImagingPortable/Point-of-Care ImagingCloud-Based Imaging InformaticsBy Portability Type: Fixed Imaging SystemsPortable/Mobile Imaging SystemsBy Source/Architecture Type: Standalone Imaging SystemsHybrid Imaging Systems (PET-CT, SPECT-CT, PET-MRI)By Application Type: CardiologyOncologyNeurologyOrthopedicsGynecology & ObstetricsPulmonologyGastroenterologyBy End User: HospitalsDiagnostic Imaging CentersAmbulatory Surgical CentersSpecialty ClinicsResearch & Academic InstitutesBy Region: North AmericaEuropeAsia-PacificLatin AmericaMiddle East & Africa
As AI-enabled imaging, photon-counting CT, and cloud-based radiology continue to mature, diagnostic imaging remains a cornerstone of modern healthcare infrastructure. For manufacturers and providers, the path forward lies in balancing continued technology investment against tightening reimbursement, while extending imaging access into outpatient, portable, and underserved care settings.
Get the Complete Diagnostics Imaging Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/diagnostic-imaging-market/
Frequently Asked Questions
Q: What is the size of the diagnostic imaging market? A: The global diagnostic imaging market is estimated at USD 26.5 billion in 2026 and is projected to reach USD 33.2 billion by 2031.
Q: What is the growth rate of the diagnostic imaging market? A: The diagnostic imaging market is projected to grow at a CAGR of 4.6% between 2026 and 2031.
Q: Which modality holds the largest share of the diagnostic imaging market? A: X-ray systems held the largest share by modality in 2025, supported by the highest global procedure volumes and lower installation and infrastructure requirements compared with other modalities.
Q: Which region leads the diagnostic imaging market? A: North America held the largest share of the diagnostic imaging market in 2025, while Asia-Pacific is the fastest-growing region through 2031.
Q: Who are the key players in the diagnostic imaging market? A: Leading companies in the diagnostic imaging market include GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, and Fujifilm Holdings.
Q: How is AI changing diagnostic imaging? A: AI is being embedded directly into image acquisition through deep learning reconstruction algorithms, reducing noise at the signal level, shortening scan times, and enabling automated lesion detection and workflow prioritization for radiologists.
Expert Profile | Mayur Jain, Wissen Research
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.
Email: mayur@wissenresearch.com
LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/
About Wissen Research
Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets
Company Contact:
Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/diagnostic-imaging-market-to-reach-us-33-2-bn-by-2031–growing-at-4-6-cagr-new-report-by-wissen-research-302881093.html
Technology
CIB closes $100 million loan with Morguard to advance building energy upgrades
Published
3 minutes agoon
September 16, 2026By
NERVA Energy to support deep energy retrofits across selected Morguard properties
Disponible en français
Morguard has established a $145 million Morguard ReNew Fund supported by its partnersThe Morguard ReNew Fund supports retrofits which will reduce energy use and help lower long-term operating costs, with a minimum 30 per cent reduction in emissionsMorguard and NERVA Energy will complete deep energy retrofits and optimization projects across a diverse portfolio of residential and commercial properties in CanadaUpgrades will modernize mechanical systems and support fuel switching to low-carbon heating and hot water options, including heat pumps and the use of district energy
TORONTO, Sept. 16, 2026 /CNW/ — The Canada Infrastructure Bank (CIB) has reached financial close on a $100 million loan with Morguard Corporation to enable energy‑efficient retrofits across a portfolio of approximately 30 properties in Canada.
Morguard is a fully integrated real estate firm with more than $24.2 billion in assets under management across North America. Morguard will collaborate with NERVA Energy, a multi‑disciplinary engineering firm specializing in energy performance, to design and implement the retrofit projects across the portfolio.
The loan, coupled with an equity commitment from Morguard and its investors through the newly established Morguard ReNew Fund, will support portfolio-scale building upgrades across Morguard’s multi-suite residential and commercial buildings, including retail, office and industrial properties. Upgrades are expected to include improvements to optimize building systems and mechanical equipment, along with low-carbon heating and hot water solutions.
NERVA Energy is serving as the technical and delivery partner, providing integrated engineering and implementation across participating properties. The projects are focused on improving building performance, reducing emissions and supporting long-term operational efficiency.
The upgrades are expected to reduce annual emissions by approximately 35,246 tonnes of CO₂e across participating properties, while improving building performance and long-term operational efficiency.
The CIB’s loan is provided through its Building Retrofits Initiative, which offers low-cost, long-term financing to help building owners overcome high upfront costs and long payback periods associated with deep energy retrofits.
Endorsements:
Delivering deep retrofits at scale takes strong collaboration between building owners, technical experts, and long‑term capital. Working with Morguard and NERVA Energy, we’re accelerating deep retrofits that reduce energy use, save owners long‑term operating expenses and cut emissions.
Ehren Cory, CEO, Canada Infrastructure Bank
Through investments like this, the Canada Infrastructure Bank is helping building owners make the upgrades needed to cut emissions, lower energy costs, and extend the life of the building. These large-scale retrofits will modernize buildings across Ontario and Quebec while supporting a cleaner economy and more resilient communities for generations to come.
Hon. Gregor Robertson, Minister of Housing and Infrastructure and Minister responsible for Pacific Economic Development Canada
This $100 million investment through the Canada Infrastructure Bank will help modernize buildings across Canada, reduce emissions by more than 35,000 tonnes annually, and improve long-term energy efficiency. By partnering with Morguard and NERVA Energy, we are supporting practical solutions that strengthen our building infrastructure while advancing Canada’s clean economy.
Hon. Shafqat Ali, President of the Treasury
Establishing the Morguard ReNew Fund, with support from CIB, advances our ongoing efforts to strengthen the performance, efficiency and resilience of our properties over time. By implementing retrofit upgrades across selected assets, we are improving building operations, reducing emissions and continuing to position our portfolio for long-term value creation.
Angela Sahi, President and Chief Executive Officer, Morguard Corporation
This is a clear example of where the industry is heading. Retrofit programs are no longer conceptual or fragmented, they are becoming structured, measurable and scalable. We are proud to support Morguard in delivering tangible performance improvements across their portfolio while advancing Canadian expertise in this space.
Rob Hallewick, Chief Executive Officer, NERVA Energy
Learn More:
Morguard Corporation
NERVA Energy
Morguard Corporation
Morguard Corporation is a real estate investment company listed on the Toronto Stock Exchange (TSX: MRC). The company and its subsidiaries, Morguard REIT (TSX: MRT.UN) and Morguard North American Residential REIT (TSX: MRG.UN), own a diversified portfolio of real estate assets across multiple classes, including office, industrial, retail, multi-suite residential and hotel. Morguard also provides real estate management services to institutional and other investors. As of June 30, 2026, Morguard’s owned and managed portfolio of assets was valued at $24.2 billion.
For more information, visit www.morguard.com or follow on LinkedIn and Instagram.
NERVA Energy
NERVA Energy is a Canadian multidisciplinary engineering firm specializing in the delivery of high-performance building retrofit solutions. Combining in-house engineering expertise with field execution capabilities, NERVA provides turnkey programs that optimize building systems, improve energy performance, and enhance overall asset quality.
With a focus on measurable outcomes and accountability, NERVA’s solutions are supported by performance guarantees, ensuring that projected results are realized in practice. The firm works with building owners and institutional partners to deliver scalable retrofit programs that improve efficiency, reduce emissions, and strengthen long-term asset performance.
SOURCE Canada Infrastructure Bank
Technology
Millennium Partners Management LLC – Notice of Data Security Incident
Published
3 minutes agoon
September 16, 2026By
NEW YORK, Sept. 16, 2026 /PRNewswire/ — Millennium Partners Management experienced data security incident involving the personal information of some customers and employees.
On April 27, 2026, Millennium discovered a network disruption. It took immediate action to secure its network and engaged outside cybersecurity specialists to investigate. As part of the investigation, Millennium learned that its network suffered unauthorized access at times between April 24, 2026, and April 26, 2026. On July 9, 2026, it confirmed that personal information from its network had been accessed and acquired. The information may have included Social Security numbers.
Upon becoming aware of the disruption, Millennium took immediate steps to secure its systems and enhance its security posture. In addition, Millennium established a toll-free professional call center to answer questions about the incident.
Generally, it is best practice to remain vigilant for risk of identity theft and fraud by reviewing and monitoring your account statements and credit reports for suspicious activity and errors. If you discover any suspicious or unusual activity on your accounts, promptly contact your financial institution or service provider. Individuals are entitled to one free credit report annually from each of the three major credit reporting bureaus: TransUnion, Experian, and Equifax. To order a free credit report, visit www.annualcreditreport.com or call 1-877-322-8228.
For further information, individuals may contact a professional call center at 1-800-405-6108, 8:00 a.m. to 8:00 p.m. Eastern Time, Monday through Friday, excluding federal holidays.
Joshua Mooney, joshua.mooney@kennedyslaw.com
View original content:https://www.prnewswire.com/news-releases/millennium-partners-management-llc—notice-of-data-security-incident-302881103.html
SOURCE Kennedys CMK LLP
Diagnostic Imaging Market to Reach US$ 33.2 Bn by 2031, Growing at 4.6% CAGR: New Report by Wissen Research
CIB closes $100 million loan with Morguard to advance building energy upgrades
Millennium Partners Management LLC – Notice of Data Security Incident
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology2 days agoHexagon Creates A Constitution for AI, Adopted and Enforced on a Public Blockchain — and Anyone Can Check It
-
Technology4 days agoLarry Ellison Cancels His Plan to Sell Oracle Stock
-
Coin Market4 days agoNvidia considers $10B investment in potential record Anthropic IPO: Reuters
-
Technology4 days agoKrelva Accepted Into the HBS Foundry Bootcamp at Harvard Business School
-
Technology4 days agoOneOdio Concludes a Successful IFA 2026 Showcase in Berlin
-
Coin Market2 days agoKraken brings DeFi yield to tokenized stocks and ETFs
-
Technology5 days agoAchieve Publishes New Online Guidance for Freedom Debt Relief and Achieve Customers
-
Technology3 days agoPANDAG G1 to Make First Official Appearance at GaLaBau 2026
